ArticleFrontiers in endocrinology2019

Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy.

Sanjay Kumar Bhadada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.